Race-neutral pulmonary function testing, now recommended by ATS and implemented at Boston Medical Center, has had a long road to acceptance.
Roche Holding AG on Friday said a therapy it co-developed with Cambridge-based Blueprint Medicines Corp was approved by the U.S. health regulator for the treatment of patients with a type of non-small ...
The FDA granted approval to nerandomilast, now Jascayd, for treating adults with idiopathic pulmonary fibrosis, marking the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback